Category Archives: research

Is MORE Research on medical cannabis needed? Always.


“More research is needed” are words that you will find written at the end of most scientific research articles.

You will probably hear it a lot if you are talking about using cannabis as medicine.

The American Academy of Neurology (AAN) recently echoed these words, along with a position statement and a request for the RECLASSIFICATION of marijuana as a Schedule I drug.

Currently research is restricted by a big ROADBLOCK which has to be removed. It is the (mis)classification of marijuana as a SCHEDULE I drug—a classification which is supposed to be for drugs that have NO medicinal value.

This severely limits who can conduct research and who gets to have access to the government’s supply of marijuana.

The AAN announced that they “support all efforts to conduct rigorous research to evaluate the long-term safety and effectiveness of marijuana-based products”.

And they added: “The AAN, for research purposes, requests the reclassification of marijuana-based products from their current Schedule 1 status so as to improve access for study of marijuana or cannabinoids under IRB-approved research protocols”.


While others are still saying “More research is needed”, The American Academy of Neurology (AAN) has gone ahead with making recommendations to physicians on the use of–certain forms of–cannabis products to treat qualifying multiple sclerosis (MS) patients. They also have a patient guide.

And, MS is one of the approved conditions in many medical marijuana programs, in many states including Hawaii.


Enough research has been done that the United States Government has multiple patents on cannabis as a therapeutic agent. One is a 2003 patent of cannabis as a neuroprotectant.  And there are more than 80 other U.S. patent (or applications for patents) HERE

And the Good News is that More US. research is coming!

In December of 2014 the state Colorado health officials awarded $8 million in research grants on to study the use of medical marijuana in the treatment of symptoms associated with Parkinson’s disease, childhood epilepsy and post-traumatic stress disorder.


While we welcome more research and wait for it,

we can follow ongoing research in Israel—

The world leader in cannabis research.


DISCLAIMER: The information provided on this Site is for educational purposes only. This article is not intended to provide medical advice, diagnosis or treatment.

Please consult a physician before beginning any treatment program or making any adjustments in your healthcare, diet, and /or lifestyle.

Do not remove yourself from any prescribed medications or treatments without consulting your doctor.

International drug law reform expert to speak in Honolulu 11/1/13

The Drug Policy Forum of Hawaii is co-founder of the Medical Cannabis Coalition of Hawaii – congratulations on 20 years serving Hawaii!

“Celebrating 20 Years of Science, Reason and Compassion ”

The Drug Policy Forum of Hawai`i’s 20th Anniversary Event
Friday, November 1, 2013
5:30 pm – 9:00 pm
Kapi`olani Community College
4303 Diamond Head Road
Ohelo Building ~ Ka`ikena Laua`e Room

HONOLULU – Thursday, October 17, 2013 – In the last twenty years, Hawai`i has enacted drug policy reforms on issues ranging from medical marijuana to treatment-instead-of-incarceration for nonviolent drug law violations with the support of the voters and the legislature. Join us to celebrate the work of those individuals and organizations that have tirelessly worked towards drug policy based on concern for human dignity, effective outcomes, public health considerations, and the well-being of individuals and communities.

Speaking will be Ethan Nadelmann Ph.D., JD., Executive Director of the Drug Policy Alliance – The Nation’s Premiere Drug Policy Organization . Mr. Nadelmann’s talk will be on “Ending the War on Drugs: Are We Really at the Tipping Point? ”

For more than two decades, Nadelmann helped build a broad-based movement for reform on the strength of a strategic insight that’s both simple and profound: The fight against repressive drug laws isn’t about championing the rights of drug users – even of a substance as popular as marijuana. It’s about fighting against federal overreach and the needless human toll of drug prohibition. Read more about Ethan at:

The dinner will also honor Professor of Law Emeritus and former Dean, University of Hawaiʻi William S. Richardson School of Law, Richard “Dick” Miller. Miller has never shied away from the new or the controversial. He arrived in Hawai`i to help establish the new law school at UH in 1973 and in 1993, 20 years later, he was one of the first Board members of the Drug Policy Forum of Hawai`i. His guidance and sharp legal mind is still a beacon for the Drug Policy Forum of Hawai’i in the roiling seas known as the war on drugs.

Tickets are $50 at the door and include a full dinner buffet and desserts. Limited seating is still available for the November 1 event. For further information, or to reserve a seat, please RSVP to or call (808) 988-4386 .

The Drug Policy Forum of Hawaii was founded in 1993 and remains Hawai`i’s voice
for pragmatic drug policies that minimize economic, social, and human costs.

Dr. Sanjay Gupta reverses position on MMJ, upcoming special: Weed

Watch the special, “Weed” on Sunday, 8/11/13:


Read the article:

In a stunning and personal reversal of his long-held skepticism of the health benefits of cannabis, Dr. Sanjay Gupta, neurosurgeon and Chief Medical Correspondent for CNN apologizes for spreading “misinformation” and supports real, independent research on medical cannabis.

“I am here to apologize.

I apologize because I didn’t look hard enough, until now. I didn’t look far enough. I didn’t review papers from smaller labs in other countries doing some remarkable research, and I was too dismissive of the loud chorus of legitimate patients whose symptoms improved on cannabis.”

“Looking forward, I am especially intrigued by studies like those in Spain and Israel looking at the anti-cancer effects of marijuana and its components. I’m intrigued by the neuro-protective study by Lev Meschoulam in Israel, and research in Israel and the United States on whether the drug might help alleviate symptoms of PTSD. I promise to do my part to help, genuinely and honestly, fill the remaining void in our knowledge.”

Prestigious medical journal releases poll, reveals broad support by physicians for medical marijauna

The New England Journal of Medicine poll results released May 30, 2013 shows that 76% of U.S. doctors in the U.S.,  78% of doctors worldwide, would personally prescribe medical marijuana to a hypothetical female patient with incurable cancer.

“Physicians in favor of medicinal marijuana often focused on our responsibility as caregivers to alleviate suffering. Many pointed out the known dangers of prescription narcotics, supported patient choice, or described personal experience with patients who benefited from the use of marijuana.”